31 search results
| 10 min read
The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world
| 8 min read
We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.
| 5 min read
Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.
| 6 min read
How can smart packaging designs help boost medical adherance?
| 5 min read
An inside view on the San Diego company working to bring drug delivering contact lenses to market.
The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.
We sit down with Albert J.R. Heck, Professor at the Science Faculty, Utrecht University, and Scientific Director of the Netherlands Proteomics Centre
Work by an international team in Japan has found a new and effective way to attack cancer inside the body.
Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.
How work on sharks could provide a highly effective weapon against new COVID variants
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
You will benefit from:
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal